Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy
Journal of Medicinal Chemistry · 10.08.2023 · 66 (15) · 10458-10472
DOI: 10.1021/acs.jmedchem.3c00587 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 06.06.2023. Verfasst von Qi He und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People's Republic of China. Hauptthemen laut MEDLINE: Transcription Factors, Neoplasms. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Higher Education Discipline Innovation Project.
Abstract (Originalsprache)
As a novel protein knockdown tool, proteolysis targeting chimeras (PROTACs) can induce potent degradation of target proteins by hijacking E3 ubiquitin ligases. However, the uncontrollable protein disruption of PROTACs is prone to cause "off-target" toxicity after systemic administration. Herein, we designed a photocaged-PROTAC (phoBET1) and loaded it in UCNPs-based mesoporous silica nanoparticles (UMSNs) to construct a NIR light-activatable PROTAC nanocage (UMSNs@phoBET1) for controllable target protein degradation. Upon NIR light (980 nm) irradiation, UMSNs@phoBET1 nanocages could be activated to release active PROTAC via a controlled pattern for degrading bromodomain-containing protein 4 (BRD4) and inducing MV-4-11 cancer cell apoptosis. In vivo experiments demonstrated that UMSNs@phoBET1 nanocages were capable of responding to NIR light in tumor tissues to achieve BRD4 degradation and effectively suppress tumor growth. This NIR light-activatable PROTAC nanoplatform compensates for the current shortcomings of short-wavelength light-controlled PROTACs and presents a paradigm for the precise regulation of PROTACs in living tissues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People's Republic of China.
- State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Advanced Pharmaceuticals and Biomaterials, China Pharmaceutical University, Nanjing 210009, People…
- Key Laboratory for Green Chemical Process of Ministry of Education, Hubei Key Laboratory of Novel Reactor and Green Chemical Technology, Hubei Engineering Research Center for Advanced Fine Chemicals, School of Chemical…
ORCID-Profile: Wenpei Fan, Wenying Yu
Förderung
- National Natural Science Foundation of China
- Higher Education Discipline Innovation Project
Zitieren
APA
He, Q., Zhou, L., Yu, D., Zhu, R., Chen, Y., Song, M., Liu, X., Liao, Y., Ding, T., Fan, W., & Yu, W. (2023). Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy. Journal of Medicinal Chemistry, 66(15), 10458-10472. https://doi.org/10.1021/acs.jmedchem.3c00587
Vancouver
He Q, Zhou L, Yu D, Zhu R, Chen Y, Song M, et al. Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy. Journal of Medicinal Chemistry. 2023;66(15):10458-10472. doi:10.1021/acs.jmedchem.3c00587
BibTeX
@article{He2023,
author = {He, Qi and Zhou, Liming and Yu, Daxin and Zhu, Ren and Chen, Yue and Song, Mingbo and Liu, Xintong and Liao, Yixian and Ding, Tong and Fan, Wenpei and Yu, Wenying},
title = {Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {15},
pages = {10458--10472},
doi = {10.1021/acs.jmedchem.3c00587}
}
EUVIMED